| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |